Daily news about corporate social responsibility, ethics and sustainability
Tags (4) : clinical development
AK0406: New Long-Acting Influenza Antiviral Approved in China
08/18/2026 | Companies
AFC,
AK0406,
antigenic drift,
antiviral drug,
antiviral drug-Fc conjugate,
antiviral therapy,
ArkBio,
Australia,
biopharmaceuticals,
China,
clinical development,
drug development,
global clinical development,
HREC,
IND approval,
infectious diseases,
influenza,
influenza A,
influenza B,
influenza prevention,
influenza prophylaxis,
influenza vaccines,
long-acting antiviral,
NMPA,
Phase I clinical trial,
preclinical studies,
prophylactic treatment,
seasonal influenza,
Shanghai Ark Biopharmaceutical,
therapeutic treatment
Kaigene Licenses KG006 Autoimmune Drug to Taisho for Japan
07/31/2026 | Companies
antibody therapeutics,
autoimmune disease treatment,
autoimmune disorders,
autoimmune therapy,
biologics,
biotech licensing,
biotechnology,
Celltrion,
clinical development,
drug commercialization,
drug licensing agreement,
FcRn inhibitor,
healthcare news,
hFcRn inhibitor,
immunology,
innovative therapeutics,
Japan pharmaceutical market,
Japanese pharma,
Kaigene,
KG006,
milestone payments,
MRCT,
Multi-Regional Clinical Trial,
neonatal Fc receptor,
next-generation antibodies,
pharmaceutical partnership,
Phase 3 clinical trial,
regulatory approval,
royalty agreement,
Taisho Pharmaceutical
Viva Biotech Expands Integrated Drug Discovery and Innovation in Europe
04/07/2026 | Companies
AI drug discovery,
AIDD,
biopharmaceutical industry,
biotechnology partnerships,
CDMO services,
clinical development,
CMC development,
cryo-EM,
drug discovery,
drug manufacturing,
Europe biotech,
integrated platforms,
life sciences,
medicinal chemistry,
membrane proteins,
peptides therapeutics,
pharmaceutical innovation,
pharmaceutical R&D,
protein structures,
research collaboration,
SBDD,
scientific innovation,
small molecules,
structural biology,
Viva Biotech
Belief BioMed & Grand Life Sciences Partner to Advance Hemophilia A Gene Therapy in China
03/23/2026 | Companies
BBM-H803,
BBM-H901,
Belief BioMed,
biotech industry,
biotechnology partnership,
China healthcare,
clinical development,
commercialization rights,
drug development,
gene therapy,
Grand Life Sciences,
healthcare innovation,
hematology,
hemophilia A,
hemophilia treatment,
innovative therapies,
medical research,
pharmaceutical collaboration,
rare diseases
Companies
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com